Adalta Ltd granted second Japanese patent for lead i-body AD-214

AdAlta Ltd (ASX:1AD) has extended the range and diversity of sequences analogous to its lead program AD-214 with the grant of a second patent in Japan by...

Related Keywords

China ,Australia ,Japan ,Melbourne ,Victoria ,India ,Hong Kong ,Singapore ,Japanese ,Tim Oldham ,Adalta Ltd ,Japanese Patent Office ,Ge Healthcare ,Japanese Patent ,Patent Number ,Idiopathic Pulmonary Fibrosis ,Carina Biotech ,